Skip to content

Michael Woudenburg

Michael Woudenburg

Company: InMed Pharmaceuticals

Job title: Vice President, Chemistry,
Manufacturing and Control (CMC)

Bio:

Mr. Woudenberg leads all aspects of CMC at InMed.  He brings over 20 years of engineering leadership and GMP manufacturing and scale-up experience in the development, technology transfer and commercialization of active pharmaceutical ingredients (APIs), including process and formulation development from lab scale through clinical development to validated and successfully approved commercial APIs. He has extensive experience with regulatory inspections (FDA, EMEA, Health Canada, etc.) and related CMC requirements from clinical to commercial production of approved products.  Mr. Woudenberg held various positions with Cardiome, Arbutus Biopharma and as Managing Director of Phyton Biotech. Mr. Woudenberg received his Bachelor’s in Chemistry and Bachelor’s of Chemical Engineering at Western University of London, Ontario, Canada.

Seminars:

Panel Discussion: Whole Plant Vs. Synthetic Cannabinoids and Their Relative Potential in Pharmaceuticals 12:15 pm

• Debate the relative importance of each source in relation to the current needs that developers have • Break down the current understanding of each source’s therapeutic potential • Consider how the rise of biosynthesis could impact cannabinoid researchRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.